Fluorouracil (injection)

Revision as of 18:10, 27 September 2011 by WikiBot (talk | contribs) (Protected "Fluorouracil": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Fluorouracil (injection)
Clinical data
Pregnancy
category
  • AU: D

  • D (intravenous), X (topical) (US)
Routes of
administration
Intravenous (infusion or bolus) and topical
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability28 to 100%
Protein binding8 to 12%
MetabolismIntracellular and hepatic (CYP-mediated)
Elimination half-life10 to 20 minutes
ExcretionRenal
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC4H3FN2O2
Molar mass130.077 g/mol

WikiDoc Resources for Fluorouracil (injection)

Articles

Most recent articles on Fluorouracil (injection)

Most cited articles on Fluorouracil (injection)

Review articles on Fluorouracil (injection)

Articles on Fluorouracil (injection) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Fluorouracil (injection)

Images of Fluorouracil (injection)

Photos of Fluorouracil (injection)

Podcasts & MP3s on Fluorouracil (injection)

Videos on Fluorouracil (injection)

Evidence Based Medicine

Cochrane Collaboration on Fluorouracil (injection)

Bandolier on Fluorouracil (injection)

TRIP on Fluorouracil (injection)

Clinical Trials

Ongoing Trials on Fluorouracil (injection) at Clinical Trials.gov

Trial results on Fluorouracil (injection)

Clinical Trials on Fluorouracil (injection) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Fluorouracil (injection)

NICE Guidance on Fluorouracil (injection)

NHS PRODIGY Guidance

FDA on Fluorouracil (injection)

CDC on Fluorouracil (injection)

Books

Books on Fluorouracil (injection)

News

Fluorouracil (injection) in the news

Be alerted to news on Fluorouracil (injection)

News trends on Fluorouracil (injection)

Commentary

Blogs on Fluorouracil (injection)

Definitions

Definitions of Fluorouracil (injection)

Patient Resources / Community

Patient resources on Fluorouracil (injection)

Discussion groups on Fluorouracil (injection)

Patient Handouts on Fluorouracil (injection)

Directions to Hospitals Treating Fluorouracil (injection)

Risk calculators and risk factors for Fluorouracil (injection)

Healthcare Provider Resources

Symptoms of Fluorouracil (injection)

Causes & Risk Factors for Fluorouracil (injection)

Diagnostic studies for Fluorouracil (injection)

Treatment of Fluorouracil (injection)

Continuing Medical Education (CME)

CME Programs on Fluorouracil (injection)

International

Fluorouracil (injection) en Espanol

Fluorouracil (injection) en Francais

Business

Fluorouracil (injection) in the Marketplace

Patents on Fluorouracil (injection)

Experimental / Informatics

List of terms related to Fluorouracil (injection)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Fluorouracil (5-FU) is a drug that is used in the treatment of cancer. It belongs to the family of drugs called antimetabolites. It is a pyrimidine analog. It is typically administered with Leucovorin.

Uses

The chemotherapy agent 5-FU (fluorouracil), which has been in use against cancer for about 40 years, acts in several ways, but principally as a thymidylate synthase inhibitor, interrupting the action of an enzyme which is a critical factor in the synthesis of the pyrimidine thymine-which is important in DNA replication [3]. Thymidylate synthase methylates deoxyuracilmonophoshate (dUMP) into deoxythyminemonophosphate (dTMP).

Some of its principal use is in colorectal cancer and pancreatic cancer, in which it has been the established form of chemotherapy for decades (platinum-containing drugs are a recent addition).

5-FU is also used in ophthalmic surgery, specifically to augment trabeculectomy (an operation performed to lower the intraocular pressure in patients with glaucoma) in patients deemed to be at high risk for failure. 5-FU acts as an anti-scarring agent in this regard, since excessive scaring at the trabeculectomy site is the main cause for failure of the surgery.

Fluorouracil can be used topically (as a cream) for treating actinic (solar) keratoses and some types of basal cell carcinomas of the skin. It is often referred to by its trade names Efudix, Carac or Fluoroplex.

Mode of action

As a pyrimidine analogue, it is transformed inside the cell into different cytotoxic metabolites which are then incorporated into DNA and RNA, finally inducing cell cycle arrest and apoptosis by inhibiting the cell's ability to synthesize DNA. It is an S-phase specific drug and only active during certain cell cycles. In addition to being incorporated in DNA and RNA, the drug has been shown to inhibit the activity of the exosome complex, an exoribonuclease complex of which the activity is essential for cell survival.

Capecitabine is a prodrug that is converted into 5-FU in the tissues. It can be administered orally.

Adverse effects

Side effects include myelosuppression, mucositis, dermatitis, diarrhea and cardiac toxicity.

When using a pyrimidine-based drug, all users must be aware that there is a genetic inability to metabolize them. Current theory points to nearly 8% of the population suffering what is termed DPD deficiency. There are laboratory tests to determine the relative activity of the DPD enzyme, but these tests are now commercially available. Thousands of patients eagerly await the increased availability of clinical DPD testing. Work in this sector has been carried out in both the U.S. and Europe. Currently there is only two labs to offer DPD testing, Coventry Diagnostics and DNAVision (Belgium). It is expected that with a potential 500,000 people in North America using the pyrimidine-based 5-FU, this form of testing will increase.

External links


Template:SIB

de:Fluorouracil


Template:WikiDoc Sources